Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Literature DB >> 26613994

Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Abstract

Behavioral disorders are common in persons infected with human immunodeficiency virus (HIV). The differential includes preexisting psychiatric diseases, substance abuse, direct effects of HIV infection, opportunistic infection, and the adverse effects of medical therapies. Many patients have more than one contributing or comorbid problem to explain these behavioral changes. The differential should always include consideration of psychosocial, genetic, and medical causes of disease. Treatment strategies must take into account the coadministration of antiretroviral therapy and the specific neurologic problems common in patients infected with HIV.

Entities: Chemical Disease Gene Species

Keywords: AIDS; Behavior; Brain; Delirium; Encephalitis; HIV; Infection

Mesh：

Year: 2016 PMID： 26613994 PMCID： PMC4663681 DOI： 10.1016/j.ncl.2015.08.003

Source DB: PubMed Journal: Neurol Clin ISSN： 0733-8619 Impact factor: 3.806

132 in total

1. Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study.

Authors: Kasane Naito; Hiroki Ueno; Mayu Sekine; Munekazu Kanemitsu; Tomohiko Ohshita; Takeshi Nakamura; Takemori Yamawaki; Masayasu Matsumoto
Journal: Intern Med Date: 2012-01-15 Impact factor: 1.271

Review 2. Neuropathological sequelae of Human Immunodeficiency Virus and apathy: A review of neuropsychological and neuroimaging studies.

Authors: Roger C McIntosh; Monica Rosselli; Lucina Q Uddin; Michael Antoni
Journal: Neurosci Biobehav Rev Date: 2015-05-02 Impact factor: 8.989

Review 3. Antiretroviral therapy-induced psychosis: case report and brief review of the literature.

Authors: R Foster; D Olajide; I P Everall
Journal: HIV Med Date: 2003-04 Impact factor: 3.180

Review 4. Mania in neurologic disorders.

Authors: M F Mendez
Journal: Curr Psychiatry Rep Date: 2000-10 Impact factor: 5.285

5. Posttraumatic stress disorder in response to HIV infection.

Authors: B Kelly; B Raphael; F Judd; M Perdices; G Kernutt; P Burnett; M Dunne; G Burrows
Journal: Gen Hosp Psychiatry Date: 1998-11 Impact factor: 3.238

6. Long-term correlates of childhood abuse among adults with severe mental illness: adult victimization, substance abuse, and HIV sexual risk behavior.

Authors: Christina S Meade; Trace S Kershaw; Nathan B Hansen; Kathleen J Sikkema
Journal: AIDS Behav Date: 2007-10-30

7. Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz.

Authors: Luis B Tovar-y-Romo; Namandjé N Bumpus; Daniel Pomerantz; Lindsay B Avery; Ned Sacktor; Justin C McArthur; Norman J Haughey
Journal: J Pharmacol Exp Ther Date: 2012-09-13 Impact factor: 4.030

Review 8. Drug-induced liver injury due to antimicrobials, central nervous system agents, and nonsteroidal anti-inflammatory drugs.

Authors: Harshad Devarbhavi; Raúl J Andrade
Journal: Semin Liver Dis Date: 2014-05-31 Impact factor: 6.115

9. Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties.

Authors: Steven A Safren; Beth S Gershuny; Ellen Hendriksen
Journal: AIDS Patient Care STDS Date: 2003-12 Impact factor: 5.078

10. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors: Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal: Arch Neurol Date: 2008-01

7 in total

Review 1. Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors: Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal: Crit Care Clin Date: 2017-07 Impact factor: 3.598

2. Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial.

Authors: Martins Nweke; Nombeko Mshunqane; Nalini Govender; Aderonke Akinpelu; Adesola Ogunniyi
Journal: JMIR Res Protoc Date: 2022-01-31

3. miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos.

Authors: Shuyuan Wu; Zhaofu Wu; Huiling Xu; Jinli Zhang; Wenyi Gu; Xiaohua Tan; Zemin Pan; Dongdong Cao; Dongmei Li; Lei Yang; Dongmei Li; Yuanming Pan
Journal: PeerJ Date: 2022-04-15 Impact factor: 3.061

4. Effects of aerobic exercise on quality of life of people with HIV-associated neurocognitive disorder on antiretroviral therapy: a randomised controlled trial.

Authors: Martins Nweke; Nombeko Mshunqane; Nalini Govender; Aderonke O Akinpelu; Adesola Ogunniyi
Journal: BMC Infect Dis Date: 2022-04-29 Impact factor: 3.667

Review 5. HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae.

Authors: Pascal Büttiker; George B Stefano; Simon Weissenberger; Radek Ptacek; Martin Anders; Jiri Raboch; Richard M Kream
Journal: Neuropsychiatr Dis Treat Date: 2022-10-05 Impact factor: 2.989

6. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.

Authors: Rowan Saloner; David J Grelotti; Griffin Tyree; Erin E Sundermann; Qing Ma; Scott Letendre; Robert K Heaton; Mariana Cherner
Journal: J Acquir Immune Defic Syndr Date: 2019-12-15 Impact factor: 3.771

7. Neurocognitive and mental health outcomes and association with quality of life among adults living with HIV: a cross-sectional focus on a low-literacy population from coastal Kenya.

Authors: Moses Kachama Nyongesa; Patrick N Mwangala; Paul Mwangi; Martha Kombe; Charles R J C Newton; Amina A Abubakar
Journal: BMJ Open Date: 2018-09-17 Impact factor: 2.692

7 in total